Pharmacokinetics and Glucodynamics of Ultra  Rapid Lispro (URLi) versus Humalog ® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial

ConclusionIn patients with T1DM, URLi showed ultra-rapid pharmacokinetics and glucodynamics, with the differences between URLi and Humalog in elderly patients mirroring those in younger adults.ClinicalTrials.gov identifier: NCT03166124.

Source: Clinical Pharmacokinetics - May 28, 2020 Category: Drugs & Pharmacology Source Type: research